The YKL202W Antibody is a custom-produced monoclonal antibody developed for research applications, primarily targeting proteins associated with Saccharomyces cerevisiae (Baker's yeast) . Antibodies like YKL202W are integral to immunological research, enabling the detection and characterization of specific antigens in biological systems. Structurally, antibodies are Y-shaped glycoproteins composed of heavy and light chains, with variable regions (paratopes) that bind to epitopes on target antigens . Their versatility in assays such as Western blotting, immunohistochemistry, and ELISA makes them critical tools in molecular biology.
The YKL202W Antibody is engineered to recognize proteins expressed in S. cerevisiae strain ATCC 204508/S288c . While specific antigen details are not fully disclosed in the available literature, yeast proteins often serve as models for studying eukaryotic cellular processes, such as metabolic regulation, stress response, or protein folding. The antibody’s reactivity is validated in assays mimicking conditions used in yeast biology research, including fixed and permeabilized cell samples .
| Property | Details |
|---|---|
| Target Organism | Saccharomyces cerevisiae (strain ATCC 204508/S288c) |
| Antigen Class | Yeast-specific protein (exact identity not specified) |
| Application | Immunohistochemistry, Western blot, ELISA |
| Format | Monoclonal antibody (customizable) |
| Source | Mammalian expression system (e.g., CHO cells) |
The YKL202W Antibody is likely used in:
Protein localization studies in yeast models to map subcellular distribution.
Western blotting for quantifying protein expression levels under varying conditions.
Immunoprecipitation to isolate protein complexes for downstream analysis .
Its specificity for yeast antigens aligns with broader trends in antibody characterization, where reagents must be rigorously validated to avoid cross-reactivity . For example, initiatives like YCharOS emphasize the importance of knockout (KO) cell line testing to ensure antibody specificity .
While the antibody’s manufacturer (Cusabio) reports validation in yeast assays , independent verification is limited. Common challenges in antibody development include:
Cross-reactivity with homologous proteins in other organisms.
Lot-to-lot variability, particularly in polyclonal antibodies .
Limited availability of KO yeast strains for comprehensive specificity testing .
| Validation Method | Outcome |
|---|---|
| ELISA | Positive binding to recombinant antigen |
| Immunohistochemistry | Specific staining in permeabilized yeast cells |
| Western Blot | Band detection at expected molecular weight |
YKL202W’s role in yeast biology research is part of a broader antibody ecosystem. Studies on SARS-CoV-2 antibodies highlight the importance of structural mapping and epitope clustering , principles that could inform future optimizations for YKL202W. Similarly, collaborations between academic labs and industry partners (e.g., NeuroMab) underscore the value of standardized protocols in antibody development.
YKL202W is a yeast gene encoding a protein involved in cellular signaling pathways. Similar to other yeast proteins like Ycx1 (encoded by YDL206W), it likely plays a specific role in yeast cell biology that can be studied using antibody-based techniques. Antibodies against YKL202W enable researchers to detect, quantify, and visualize this protein in various experimental contexts.
Antibodies against yeast proteins typically recognize specific epitopes and can be used to determine protein expression levels, subcellular localization, and protein-protein interactions. When studying yeast proteins like YKL202W, researchers should consider that these proteins often have specialized functions within cellular compartments, similar to how YDL206W localizes to the endoplasmic reticulum and Golgi apparatus and influences calcium signaling pathways .
Binary validation approaches represent one of the most effective strategies for evaluating antibody specificity before experimental use. This involves testing the antibody in both positive and negative expression systems to confirm target recognition without cross-reactivity.
For YKL202W antibodies, validation should include:
Endogenous controls: Testing in yeast strains known to express or lack YKL202W
Genetic knockouts: Comparing antibody signal between wild-type and YKL202W deletion strains
Western blot validation: Confirming single-band specificity at the expected molecular weight
Cross-application validation: Verifying specificity across different applications (WB, IHC, IF)
As illustrated in antibody validation literature, each model used for binary validation should be tested in every intended application, as specificity in one application (e.g., Western blot) does not guarantee specificity in another (e.g., immunohistochemistry) .
For optimal Western blot results with YKL202W antibodies, consider the following methodological approach:
Sample preparation: Prepare yeast lysates using glass bead disruption in buffer containing protease inhibitors
Protein loading: Load 20-50 μg of total protein per lane, with β-actin as loading control
Gel selection: Use 10-12% SDS-PAGE gels for optimal resolution of YKL202W
Transfer conditions: Transfer to PVDF membrane at 100V for 1 hour or 30V overnight
Blocking: Block with 5% non-fat milk in TBST for 1 hour at room temperature
Primary antibody: Optimize dilution (typically 1:1000 to 1:5000) in blocking buffer; incubate overnight at 4°C
Controls: Include positive controls (expressing YKL202W) and negative controls (deletion strains)
Researchers should validate antibody specificity by checking for a single band at the expected molecular weight, similar to the binary testing approach shown for other antibodies in Figure 1 of standard validation protocols, where specific antibodies demonstrate clear discrimination between positive and negative cell lines .
Determining optimal antibody concentration for immunohistochemistry requires systematic titration:
Initial range finding: Test 3-4 dilutions spanning a wide range (e.g., 1:100, 1:500, 1:1000, 1:5000)
Fine-tuning: Narrow the dilution range based on initial results
Control inclusion: Always include positive and negative controls in each experiment
Evaluation criteria:
Follow a similar approach to that shown in Figure 2 of standard IHC validation protocols, where positive cell pellets (expressing the target protein) show strong staining while negative cell pellets show minimal background, confirming specificity of the antibody .
YKL202W antibodies can be powerful tools for investigating protein-protein interactions through several methodological approaches:
Co-immunoprecipitation (Co-IP):
Lyse yeast cells under non-denaturing conditions
Incubate lysate with YKL202W antibody conjugated to protein A/G beads
Wash complexes and elute
Analyze interacting partners by mass spectrometry or Western blot
Proximity Ligation Assay (PLA):
Fix yeast cells and permeabilize
Incubate with YKL202W antibody and antibody against potential interacting partner
Add PLA probes, ligase, and polymerase
Visualize interaction signals by fluorescence microscopy
Pull-down assays with recombinant proteins:
This approach parallels methods used to study signaling pathway components in yeast, such as those employed to characterize the Ycx1 protein's role in calcium and calcineurin signaling .
Addressing cross-reactivity requires a multi-faceted approach:
Epitope mapping:
Identify the specific region recognized by the antibody
Compare with homologous proteins to predict potential cross-reactivity
Use peptide competition assays to confirm epitope specificity
Pre-adsorption controls:
Pre-incubate antibody with purified YKL202W protein
Compare signal between pre-adsorbed and non-adsorbed antibody
Reduction in signal indicates specificity
Multiple antibody validation:
Use antibodies targeting different epitopes of YKL202W
Compare signal patterns across experiments
Consistent results with different antibodies increase confidence
Genetic control experiments:
These approaches parallel binary validation strategies described in antibody validation literature, where endogenous controls with variable expression levels provide confidence in specificity .
Studying YKL202W localization during stress requires careful experimental design:
Time-course experiments:
Subject yeast cells to relevant stressors (oxidative stress, heat shock, nutrient deprivation)
Fix cells at defined time points (0, 15, 30, 60 min, etc.)
Perform immunofluorescence with YKL202W antibodies
Co-stain with organelle markers (nuclear, ER, Golgi, mitochondrial)
Live-cell imaging:
Create strains expressing fluorescent protein-tagged YKL202W
Validate tag function using YKL202W antibodies
Perform time-lapse microscopy during stress application
Analyze dynamics of localization changes
Biochemical fractionation:
This parallels approaches used to determine subcellular localization of yeast proteins like YDL206W, which was found to localize to the endoplasmic reticulum and Golgi through subcellular localization studies .
To study YKL202W phosphorylation states:
Phospho-specific antibody development:
Generate antibodies against predicted phosphorylation sites
Validate using phosphatase treatments as negative controls
Confirm with kinase assays as positive controls
Quantitative phosphoproteomics:
Immunoprecipitate YKL202W using total protein antibodies
Analyze phosphorylation by mass spectrometry
Use phospho-specific antibodies to confirm sites
Multiplexed detection methods:
Implement multiplexed Western blotting with total and phospho-antibodies
Use fluorescent secondary antibodies for simultaneous detection
Quantify phosphorylation/total protein ratios
In-cell validation:
This approach is similar to target antigen modification validation methods that involve using treatments to induce or inhibit post-translational modifications of protein targets, as described in antibody validation literature .
Optimizing immunoprecipitation with YKL202W antibodies requires systematic protocol refinement:
Antibody amount optimization:
Test a range (1-10 μg) of antibody per reaction
Determine minimum amount needed for efficient target capture
Lysate preparation optimization:
Test different lysis buffers (varying detergents and salt concentrations)
Optimize cell disruption methods for yeast cells (glass beads, enzymatic digestion)
Include appropriate protease/phosphatase inhibitors
Binding conditions optimization:
Compare different incubation times (1 hour vs. overnight)
Test various temperatures (4°C vs. room temperature)
Evaluate different binding matrices (protein A/G, magnetic vs. agarose)
Wash stringency balance:
Develop a washing protocol that removes non-specific interactions
Maintain specific interactions by optimizing detergent and salt concentrations
Consider including competitors for common non-specific interactions
Elution method selection:
This systematic approach parallels binary validation strategies where experimental conditions are carefully optimized to ensure specificity and sensitivity .
When encountering weak or absent signals, implement this troubleshooting workflow:
| Problem | Potential Causes | Solutions |
|---|---|---|
| No signal | Protein expression too low | Use enrichment techniques before detection |
| Antibody concentration insufficient | Increase antibody concentration | |
| Epitope masked/destroyed | Try different extraction methods | |
| Detection system insensitive | Switch to more sensitive detection method | |
| Weak signal | Insufficient antibody | Increase concentration or incubation time |
| Inefficient protein transfer | Optimize transfer conditions | |
| Poor sample preparation | Improve lysis protocol, add protease inhibitors | |
| Suboptimal blocking | Test alternative blocking reagents | |
| High background | Excessive antibody | Dilute antibody further |
| Insufficient washing | Increase wash duration and frequency | |
| Non-specific binding | Add blocking proteins to antibody diluent | |
| Cross-reactivity | Try more specific antibody or pre-adsorption |
This troubleshooting approach draws on principles established in the binary validation strategy, which emphasizes the importance of appropriate positive and negative controls to ensure reliable results .
Comprehensive controls for immunofluorescence microscopy should include:
Primary antibody controls:
Omission control: no primary antibody to assess secondary antibody specificity
Isotype control: irrelevant primary antibody of same isotype
Concentration-matched pre-immune serum for polyclonal antibodies
Genetic controls:
YKL202W deletion strains as negative controls
YKL202W overexpression strains as positive controls
Tagged YKL202W strains for co-localization validation
Signal specificity controls:
Peptide competition: pre-incubate antibody with purified antigen
Antibody dilution series to demonstrate dose-dependent signal
Multiple antibodies targeting different epitopes
Subcellular marker controls:
This parallels the approach shown in Figures 1 and 2 of standard validation protocols, where antibodies are validated across multiple applications using appropriate positive and negative controls .
When designing experiments to study YKL202W interactions across genetic backgrounds:
Experimental design framework:
Select appropriate yeast strains (wild-type, mutants affecting pathways of interest)
Ensure consistent culture conditions across all strains
Process all samples in parallel to minimize technical variation
Interaction detection methods:
Co-immunoprecipitation with YKL202W antibodies
Bimolecular fluorescence complementation (BiFC)
Förster resonance energy transfer (FRET)
Yeast two-hybrid screening with YKL202W as bait
Quantification approaches:
Quantitative Western blotting for co-IP samples
Fluorescence intensity measurements for BiFC/FRET
Statistical analysis to determine significance of differences
Validation strategy:
This experimental design strategy parallels approaches used to study protein functions in yeast signaling pathways, such as those employed to characterize Ycx1's role in calcium signaling networks .
When analyzing Western blot data from YKL202W antibody experiments, implement these statistical approaches:
Quantification procedure:
Use specialized software (ImageJ, Image Lab, etc.) for densitometry
Normalize target protein bands to loading controls (β-actin, GAPDH)
Express results as relative band intensity
Statistical testing:
For two-group comparisons: Student's t-test or Mann-Whitney U test
For multiple groups: ANOVA with appropriate post-hoc tests
For time-course experiments: repeated measures ANOVA
Technical considerations:
Perform experiments in biological triplicates (minimum)
Test for normal distribution before selecting parametric/non-parametric tests
Report both effect size and p-values
Visualization methods:
This analytical approach aligns with the ranged validation strategy, where multiple samples with varying expression levels are quantitatively compared to establish antibody reliability across a spectrum of target concentrations .
Integrating multiple antibody-based techniques requires a strategic methodological approach:
Complementary technique selection:
Western blot: quantitative expression analysis
Immunoprecipitation: protein interaction studies
Immunofluorescence: subcellular localization
ChIP: DNA binding and transcriptional regulation (if applicable)
Data integration framework:
Create standardized experimental conditions across techniques
Develop consistent data normalization methods
Implement cross-validation between techniques
Functional correlation analysis:
Compare protein expression (Western blot) with localization patterns
Correlate interaction partners (co-IP) with functional pathways
Link post-translational modifications to subcellular distribution
Systems biology approach:
This integrated approach parallels comprehensive antibody validation strategies that employ multiple testing methods to build confidence in antibody specificity and performance across different applications .
Utilizing YKL202W antibodies for high-throughput screening requires specialized methodological considerations:
Assay development:
Adapt antibody-based detection to microplate format
Optimize primary and secondary antibody concentrations
Develop appropriate positive and negative controls
Establish Z-factor to validate assay robustness
Screening approaches:
ELISA-based detection for quantitative measurement
Automated immunofluorescence for localization studies
Protein array applications for interaction screening
Automation considerations:
Liquid handling optimization for antibody dispensing
Incubation time and temperature standardization
Washing protocol development for consistent background reduction
Data analysis pipeline:
This high-throughput approach builds upon established antibody validation methods, extending them to large-scale applications while maintaining the specificity and reliability principles demonstrated in binary and ranged validation strategies .
Investigating post-translational modifications (PTMs) of YKL202W requires specialized antibody applications:
PTM-specific antibody selection:
Phospho-specific antibodies for kinase pathway studies
Ubiquitin-specific antibodies for degradation studies
Acetylation/methylation antibodies for epigenetic regulation
Validation of PTM-specific antibodies:
Test specificity using enzymes that add/remove modifications
Compare wild-type to mutant proteins lacking modification sites
Perform peptide competition with modified and unmodified peptides
Experimental approaches:
Western blot with PTM-specific antibodies
Immunoprecipitation with total protein antibody followed by PTM detection
Mass spectrometry validation of detected modifications
Functional correlation:
This specialized approach parallels target antigen modification validation methods described in antibody validation literature, where treatments to induce or inhibit post-translational modifications are used to validate antibody specificity .